$527.78
-19.89-3.63%
At close: -
$529.40
1.620.31%
After Hours: May 9, 6:03 PM EDT
Comments
Loading...
Regeneron Pharmaceuticals Stock Guidance | NASDAQ:REGN | Benzinga
Regeneron Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc (REGN) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Regeneron Pharmaceuticals (REGN)?
There have been no specific sales or earnings guidance reported for Regeneron Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
